Strides Pharma develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatment
Strides Pharma Science Ltd on Wednesday said it has developed and
commercialised Favipiravir antiviral tablets and stressed that the
drug has demonstrated positive outcomes in COVID-19 treatment
globally.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-develops-favipiravir-antiviral-tablets-drug-shows-positive-outcome-in-covid-19-treatment/articleshow/75445430.cms
commercialised Favipiravir antiviral tablets and stressed that the
drug has demonstrated positive outcomes in COVID-19 treatment
globally.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-develops-favipiravir-antiviral-tablets-drug-shows-positive-outcome-in-covid-19-treatment/articleshow/75445430.cms
Comments
Post a Comment